Myeloproliferative Disorders (Pathology)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/142

encourage image

There's no tags or description

Looks like no tags are added yet.

143 Terms

1
New cards
What are myeloproliferative neoplasms (MPNs)?
Chronic clonal blood cancers of the bone marrow that usually produce mature functional blood cells and arise from an abnormal mutated stem cell clone
2
New cards
What are the defining features of MPNs?
Marrow hypercellularity, increased haemopoiesis, elevated peripheral blood counts, and a group of interlinked clonal diseases
3
New cards
What is the definition of MPN according to the lecture?
Clonal disorders of hematopoietic stem cells characterized by proliferation of one or more myeloid lineages leading to increased numbers of mature and functional blood cells in the peripheral blood
4
New cards
Which myeloid lineages may proliferate in MPNs?
Granulocytic, erythroid, and megakaryocytic lineages
5
New cards
What can MPNs eventually evolve into?
Bone marrow failure or acute leukaemia
6
New cards
What bone marrow features were seen in the clinical case suggesting an MPN?
Hypercellular marrow, increased WBC precursors, increased myelocytes, metamyelocytes, band cells, neutrophils, and megakaryocytes
7
New cards
What are the four major myeloproliferative neoplasms discussed in the lecture?
Chronic Myeloid Leukaemia (CML), Polycythaemia Vera (PV), Essential Thrombocythaemia (ET), and Primary Myelofibrosis (PMF)
8
New cards
Which mutations are commonly associated with MPNs?
JAK2, CALR, and MPL mutations
9
New cards
Which JAK2 mutations are specifically mentioned in the lecture?
JAK2 V617F point mutation and Exon 12 mutations
10
New cards
What pathway is constitutively activated by JAK2 mutations?
JAK-STAT signaling pathway
11
New cards
What occurs at codon V617F in the JAK2 mutation?
A single nucleotide change switches valine to phenylalanine
12
New cards
What is the hallmark driver mutation of Polycythaemia Vera?
JAK2 V617F mutation
13
New cards
In what percentage of PV cases is JAK2 V617F found according to the lecture?
Over 95% of cases
14
New cards
In what percentage of ET and PMF cases is JAK2 V617F found according to the lecture?
50–60% of cases
15
New cards
What does JAK stand for?
Janus Kinase
16
New cards
What does STAT stand for?
Signal Transducer and Activator of Transcription
17
New cards
Describe the JAK-STAT pathway shown in the lecture.
EPO/TPO/G-CSF binds receptor → JAK2 activated → STAT activated → nucleus → gene transcription → blood cell production
18
New cards
What ability do cells in chronic MPNs possess?
The capacity to circulate and home to secondary haemopoietic organs such as the spleen
19
New cards
What is extramedullary haematopoiesis?
Haematopoiesis occurring outside the bone marrow, particularly in organs like the spleen
20
New cards
What common organ finding occurs in all chronic MPNs?
Varying degrees of splenomegaly
21
New cards
What is the spent phase (burnt-out phase) of MPNs?
A phase characterized by marrow fibrosis and peripheral blood cytopenias
22
New cards
Can all chronic MPNs progress to acute leukaemia?
Yes, but only CML does so invariably
23
New cards
What clinical findings were present in the initial MPN case?
Intermittent fever, body ache, tiredness, weight loss, and splenomegaly
24
New cards
What CBC abnormalities were found in the initial MPN case?
Hb 9.2 g/dL, WBC 90,000/cumm, immature WBCs 20%, and platelets 850,000/cumm
25
New cards
Define Polycythaemia Vera (PV).
A neoplasm arising in a multipotent myeloid stem cell characterized by increased proliferation and production of erythroid, granulocytic, and megakaryocytic elements
26
New cards
What are the peripheral blood findings in PV?
Erythrocytosis (polycythaemia), granulocytosis, and thrombocytosis
27
New cards
What is responsible for most clinical symptoms in PV?
Absolute increase in red cell mass
28
New cards
How do PV progenitor cells respond to erythropoietin?
They require extremely small amounts of erythropoietin and other haemopoietic growth factors for proliferation and survival
29
New cards
What are serum erythropoietin levels like in PV?
Virtually undetectable
30
New cards
What additional information is required when investigating a suspected PV patient?
Smoking history, place of origin, BMI, kidney status, chronic cough history, and JAK2 V617F mutation study
31
New cards
What is the bone marrow appearance in PV?
Hypercellular marrow with some residual fat possibly present
32
New cards
What happens to erythroid progenitors in PV marrow?
They are increased, although the increase may be subtle
33
New cards
What happens to granulocytic precursors in PV marrow?
Increased numbers of maturing granulocytic precursors
34
New cards
What happens to megakaryocytes in PV marrow?
Increased numbers of megakaryocytes
35
New cards
What marrow fibrotic change can occur in PV?
Moderate to marked increase in reticulin fibres in about 10% of cases
36
New cards
Why does mild organomegaly occur in early PV?
Due to congestion, while extramedullary haematopoiesis is still minimal
37
New cards
What peripheral smear findings may be seen in PV?
Mild neutrophilia and occasional basophils
38
New cards
How does PV progress over time?
Marrow fibrosis develops leading to a spent phase, followed by extramedullary haematopoiesis and increased splenic and liver enlargement
39
New cards
Can PV transform into AML?
Yes
40
New cards
What is the typical age range for PV?
40–80 years
41
New cards
What is the median age of onset for PV?
60 years
42
New cards
Which sex is affected more frequently by PV?
Males are affected slightly more than females
43
New cards
In which ethnic group is PV incidence stated to be higher?
Jews of European origin
44
New cards
What are PV symptoms primarily related to?
Increased red cell mass
45
New cards
What haematocrit level is commonly seen in PV?
60% or more
46
New cards
What haemoglobin levels may be seen in PV?
Between 14 and 28 g/dL
47
New cards
What vascular changes occur due to increased red cell mass in PV?
Increased total blood volume, vascular distension, and vascular stasis, especially in veins
48
New cards
What does plethoric or ruddy cyanosis in PV result from?
Stagnation of blood flow
49
New cards
What percentage of PV patients are hypertensive?
Approximately 70%
50
New cards
What common neurological symptoms occur in PV?
Headache and dizziness
51
New cards
What gastrointestinal symptom association exists in PV?
Gastrointestinal symptoms are common
52
New cards
Why do PV patients develop intense pruritus?
Increased histamine release from basophils
53
New cards
Why is peptic ulceration increased in PV?
Increased histamine release from basophils
54
New cards
Why can hyperuricemia occur in PV?
Due to high cell turnover
55
New cards
What percentage of PV patients develop gout?
5–10%
56
New cards
Why are both thrombosis and bleeding increased in PV?
Due to abnormal blood flow and abnormal platelet function
57
New cards
What percentage of PV patients initially present with thrombotic episodes?
25%
58
New cards
What major thrombotic complications can occur in PV?
DVT, acute myocardial infarction, and stroke
59
New cards
What hepatic venous thrombosis is classically associated with PV?
Budd-Chiari syndrome
60
New cards
What mesenteric vascular complication can occur in PV?
Mesenteric vein thrombosis leading to bowel infarction
61
New cards
What cerebral vascular thrombosis can occur in PV?
Venous sinus thrombosis leading to haemorrhagic stroke
62
New cards
What major bleeding complication may occur after surgery in PV?
Uncontrollable bleeding
63
New cards
What minor bleeding manifestations occur in PV?
Epistaxis and bleeding gums
64
New cards
How can chronic bleeding affect PV patients?
It may cause iron deficiency that inhibits erythropoiesis
65
New cards
How does blood appear during venipuncture in PV?
Dark, thick, viscous blood that clots readily
66
New cards
What WBC range may be seen in PV?
12,000–50,000 cells/mm³
67
New cards
What happens to alkaline phosphatase levels in PV?
They are above normal
68
New cards
Is the Philadelphia chromosome present in PV?
No, it is absent
69
New cards
What platelet morphology may be seen in PV?
Giant platelets
70
New cards
What proportion of PV patients develop spent phase myelofibrosis with myeloid metaplasia?
15–20%
71
New cards
When does spent phase myelofibrosis typically develop in PV?
After approximately 10 years
72
New cards
What occurs in the spleen during the spent phase of PV?
Extramedullary haematopoiesis
73
New cards
How do arterial blood gases differ between PV and secondary polycythaemia?
Oxygen saturation is normal in PV and decreased in secondary polycythaemia
74
New cards
What exception exists to the oxygen saturation rule in secondary polycythaemia?
EPO-producing renal tumours may have normal oxygen saturation
75
New cards
How do erythropoietin levels differ between PV and secondary polycythaemia?
Low in PV and elevated in secondary polycythaemia
76
New cards
What happens to serum uric acid levels in PV?
They are increased
77
New cards
What percentage of PV cases can transform into AML?
Approximately 2%
78
New cards
What AML risk occurs after myelosuppressive therapy or marrow irradiation with radioactive phosphorus in PV?
About 15% may develop AML
79
New cards
Does PV transform into ALL?
No ALL transformation occurs
80
New cards
What is the treatment of choice for PV?
Repeated phlebotomy to keep red cell mass under control
81
New cards
What is Essential Thrombocythaemia (ET) also termed?
Essential Thrombocytosis
82
New cards
Which MPN is the least common according to the lecture?
Essential Thrombocythaemia
83
New cards
Which lineage is predominantly affected in ET?
Megakaryocytic elements
84
New cards
What platelet count exceeds the diagnostic threshold in ET according to the lecture?
More than 600,000/mm³
85
New cards
What WHO platelet threshold is stated for ET?
≥450 × 10⁹/L
86
New cards
What type of diagnosis is ET?
A diagnosis of exclusion
87
New cards
What reactive causes must be excluded before diagnosing ET?
Reactive thrombocytosis from inflammatory diseases and asplenism
88
New cards
What is the pathogenic basis of ET according to the lecture?
Unknown
89
New cards
Why is bone marrow examination important in ET?
To exclude other chronic MPNs
90
New cards
What is the bone marrow cellularity in ET?
Usually mildly to moderately increased
91
New cards
What megakaryocyte changes are seen in ET?
Markedly increased megakaryocytes including abnormally large forms
92
New cards
What happens to reticulin fibres in ET?
Minimal increase
93
New cards
What peripheral smear findings are seen in ET?
Abnormally large platelets and mild leukocytosis
94
New cards
What are the major clinical manifestations of ET?
Thrombosis and haemorrhage
95
New cards
Why do thrombosis and haemorrhage occur in ET?
Due to qualitative and quantitative platelet abnormalities
96
New cards
What is the clinical course of ET?
Indolent disorder
97
New cards
What is the median survival in ET?
12–15 years
98
New cards
Define Primary Myelofibrosis (PMF).
Neoplastic transformation of a multipotent myeloid stem cell with early progression to marrow fibrosis
99
New cards
What other chronic MPN phase is PMF histologically identical to?
The spent phase of other chronic MPNs
100
New cards
How does marrow fibrosis affect haemopoiesis in PMF?
Suppresses bone marrow haemopoiesis leading to peripheral blood cytopenias